Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study-Reference-Cited by-同舟云学术

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

Published:2012-12-13 Issue:1 Volume:30 Page:46-55
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

,Orchard T. J.,Temprosa M.,Barrett-Connor E.,Fowler S. E.,Goldberg R. B.,Mather K. J.,Marcovina S. M.,Montez M.,Ratner R. E.,Saudek C. D.,Sherif H.,Watson K. E.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2012.03750.x/fullpdf

Reference30 articles.

1. Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study;Fuller;Lancet,1980

2. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies;Edelstein;Diabetes,1997

3. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin;Diabetes Prevention Program Research Group;N Engl J Med,2002

4. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study;Pan;Diabetes Care,1997

5. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes;Scientific Reports;2024-09-08

2. Comparing Three Evidence-Based Strategies to Reduce Cardiovascular Disease Burden:An Individual-Based Cardiometabolic Policy Simulation;2024-08-03

3. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study;PLOS Medicine;2024-07-09

4. Deciphering the Effects of Semaglutide Across the Glycemic Spectrum;Diabetes Care;2024-06-22

5. Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT;Diabetes Care;2024-06-22